DadFinStart your free week
DadFin › Stocks › Real Estate › MPT

Medical Properties Trust, Inc. (MPT) stock score

Real Estate · REIT - Healthcare Facilities · United States

$3.14 ▼ -1.57% today

26.0
Dad Score, out of 100
weak

Medical Properties Trust, Inc. (MPT) is a REIT - Healthcare Facilities company in the Real Estate sector, listed in the United States. On DadFin's weekly run it scores 26.0 out of 100 on the Dad Score, a weak reading that places the business ahead of 26% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Real Estate it ranks #191 of 240. Its strongest axis is liquidity; its weakest are valuation and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Average
Growth
Average
Price action
Below average
Risk
Below average
Conviction
Below average
Liquidity
Above average
Macro
Below average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)65.4×
Dividend yield10.39%
Return on capital-1.7%
Operating margin57.4%
Revenue growth (YoY)-2.4%
FCF yield2.1%
Net debt / EBITDA9.81×
Piotroski F-Score3 / 9
52-week change-34.6%
Market cap$2.0B
Next earningsOct 29, 2026

What subscribers see on MPT

Start your free weekSubscriber? Open the full research →

REIT - Healthcare Facilities peers

StockCompanyDad ScoreBandMarket cap
WELLWelltower Inc.46.6middling$164.1B
VTRVentas, Inc.41.7middling$43.1B
OHIOmega Healthcare Investors, Inc.77.0good$14.4B
DOCHealthpeak Properties, Inc.37.7weak$13.8B
AHRAmerican Healthcare REIT, Inc.51.5middling$11.1B
CTRECareTrust REIT, Inc.29.1weak$8.6B
SBRASabra Health Care REIT, Inc.35.0weak$4.9B
NHINational Health Investors, Inc.82.4good$3.2B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.